Casey Woodring
Stock Analyst at JP Morgan
(0.65)
# 3,728
Out of 4,711 analysts
28
Total ratings
27.78%
Success rate
-15.7%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $71.65 | +31.19% | 5 | Nov 5, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $375 → $280 | $207.51 | +34.93% | 4 | Oct 25, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | $270 → $205 | $185.77 | +10.35% | 5 | Aug 8, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $52 → $54 | $44.67 | +20.89% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.64 | +64.84% | 3 | May 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $44.84 | -17.48% | 3 | Feb 14, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $26.71 | -13.89% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $13.24 | +35.95% | 2 | Jan 23, 2023 |
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $71.65
Upside: +31.19%
ICON Public Limited Company
Oct 25, 2024
Maintains: Overweight
Price Target: $375 → $280
Current: $207.51
Upside: +34.93%
Charles River Laboratories International
Aug 8, 2024
Downgrades: Neutral
Price Target: $270 → $205
Current: $185.77
Upside: +10.35%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $44.67
Upside: +20.89%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.64
Upside: +64.84%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $44.84
Upside: -17.48%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $26.71
Upside: -13.89%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $13.24
Upside: +35.95%